HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central administration of prolactin-releasing peptide shifts the utilities of metabolic fuels from carbohydrate to lipids in chicks.

Abstract
We have recently identified prolactin (PRL)-releasing peptides (PrRPs) and their stimulating effects on feeding behavior in chicks. To investigate further metabolic functions of PrRP, the present study was performed to clarify whether intracerebroventricular (ICV) injection of PrRP31, an active form of PrRP in chicks, affects heat production (HP), respiratory quotient (RQ) and plasma concentrations of metabolic fuels in chicks. The ICV injection of PrRP31 (94 and 375 pmol) did not affect HP but significantly lowered RQ. The change in RQ implies that PrRP31 shifted the utility of metabolic fuels in the body. This idea was confirmed by subsequent results in which ICV injection of PrRP31 significantly reduced glucose but increased non-esterified fatty acid concentrations in plasma. These shifts in blood metabolic fuels would not be through the increased plasma insulin, because the ICV injection of PrRP31 significantly decreased plasma insulin concentration. On the other hand, ICV injection of another orexigenic peptide, neuropeptide Y (NPY) also induced the insulin release and the metabolic effects were similar to those of PrRP31. Because ICV injection of PrRP31 increased NPY mRNA in the diencephalon, the NPY may mediate the metabolic functions of PrRP31. In summary, the present study suggests that central PrRP31 shifts the utilities of peripheral energy sources, which is not via hyperinsulinemia but via the diencephalon.
AuthorsTetsuya Tachibana, Shunsuke Moriyama, Md Sakirul Islam Khan, Tatsuya Sakamoto
JournalPhysiology & behavior (Physiol Behav) Vol. 120 Pg. 40-5 (Aug 15 2013) ISSN: 1873-507X [Electronic] United States
PMID23816984 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013.
Chemical References
  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Insulin
  • Neuropeptide Y
  • Prolactin-Releasing Hormone
  • RNA, Messenger
  • Triglycerides
  • Carbon Dioxide
Topics
  • Animals
  • Animals, Newborn
  • Blood Glucose (metabolism)
  • Carbohydrate Metabolism (drug effects)
  • Carbon Dioxide (metabolism)
  • Chickens (physiology)
  • Diencephalon (drug effects, metabolism)
  • Fatty Acids, Nonesterified (blood)
  • Injections, Intraventricular
  • Insulin (blood)
  • Lipid Metabolism (drug effects)
  • Male
  • Neuropeptide Y (biosynthesis, pharmacology)
  • Oxygen Consumption (drug effects)
  • Prolactin-Releasing Hormone (administration & dosage, pharmacology)
  • RNA, Messenger (biosynthesis, genetics)
  • Thermogenesis (drug effects)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: